Development of a novel, sensitive translational immunoassay to detect plasma glial fibrillary acidic protein (GFAP) after murine traumatic brain injury

BACKGROUND: Glial fibrillary acidic protein (GFAP) has emerged as a promising fluid biomarker for several neurological indications including traumatic brain injury (TBI), a leading cause of death and disability worldwide. In humans, serum or plasma GFAP levels can predict brain abnormalities includi...

Descripción completa

Detalles Bibliográficos
Autores principales: Button, Emily B., Cheng, Wai Hang, Barron, Carlos, Cheung, Honor, Bashir, Asma, Cooper, Jennifer, Gill, Jasmine, Stukas, Sophie, Baron, David C., Robert, Jerome, Rowe, Elyn M., Cripton, Peter A., Wellington, Cheryl L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7938597/
https://www.ncbi.nlm.nih.gov/pubmed/33678186
http://dx.doi.org/10.1186/s13195-021-00793-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7938597/
https://www.ncbi.nlm.nih.gov/pubmed/33678186
http://dx.doi.org/10.1186/s13195-021-00793-9

Ejemplares similares